Stock ScreenerStock IdeasLow P/E RatioLow P/E Ratio StocksCompanies with P/E ratios below their industry and market average, with a minimum market cap of $250M+
Stock ScreenerStock IdeasLow P/E Ratio
Market Cap: >= $250M
P/E vs Industry: Pass
P/E vs Market: Pass
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XOMA | XOMA ROYALTY CORP | $32.79 | N/A | N/A | 40.48x | 59.25x | 8.45x | 4.62x | N/A | -$12.41M | -3.12% | $87.94M | 7.25 | $447.48M | 16.73 | ||
| UI | UBIQUITI INC | $532.10 | N/A | N/A | 40.65x | 43.85x | 11.68x | 38.86x | N/A | $589.67M | 1.83% | $828.44M | 13.69 | $32.18B | 33.89 | ||
| RMBS | RAMBUS INC | $87.70 | $26.75 | 227.83% | 41.17x | 34.46x | 13.91x | 7.33x | 2.25x | $292.37M | 3.10% | $1.29B | 11.97 | $9.41B | 30.38 | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | $84.17 | $34.12 | 146.67% | 41.88x | 22.25x | 3.38x | 3.26x | 1.38x | $206.93M | 4.15% | $1.53B | 25.82 | $5.42B | 17.31 | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $13.78 | N/A | N/A | 43.06x | -42.27x | 6.26x | 3.65x | N/A | $145.02M | 12.77% | $245.84M | 2.98 | $724.20M | 23.91 | ||
| ARL | AMERICAN REALTY INVESTORS INC | $15.55 | N/A | N/A | 43.19x | N/A | 5.12x | 0.41x | N/A | -$106.07M | -42.23% | $607.77M | 37.63 | $448.49M | 17.34 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.